Using Telemedicine to Treat Opioid Use DisorderTHURSDAY, OCTOBER 11, 2018
To combat limited access to medication-assisted treatment (MAT) of opioid use disorder (OUD) in rural areas, the Drug Enforcement Administration (DEA) and U.S. Department of Health and Human Services (HHS) has developed Telemedicine and Prescribing Buprenorphine for the Treatment of Opioid Use Disorder to help clarify how clinicians can use telemedicine as a tool to expand buprenorphine-based MAT for OUD treatment under current DEA regulations. This guidance includes a clinical case example.
Recent News & Events
Enhancing Your Safety Culture
99999989When you think of organizational culture, what comes to mind? Perhaps you think of a just culture or a learning culture. But, have you considered a patient safety culture? We know...
Constellation Announces Strategic Partnership with Health Care IT Security Company Imprivata
99999989Constellation has announced a strategic partnership with Imprivata®, a health care IT security...
Together for the Common Good: Constellation and CRICO Strategies
99999989Through a partnership with CRICO Strategies, Constellation and MMIC are able to dive into medical professional liability (MPL) claim data to identify and guide process changes that reduce diagnostic error...